转移
粘附
二甲基亚砜
癌症研究
中性粒细胞胞外陷阱
运动性
细胞外
细胞粘附
癌症
体内
医学
药理学
内科学
生物
炎症
化学
细胞生物学
生物技术
有机化学
作者
Jiafeng Wang,Yechun Wang,Jun Li,J. Ying,Yongli Mu,Xuanhao Zhang,Xuefei Zhou,Limei Sun,Haiping Jiang,Wei Zhuo,Youqing Shen,Tianhua Zhou,Xiangrui Liu,Quanling Zhou
标识
DOI:10.1002/adma.202400894
摘要
Abstract Peritoneal metastasis (PM) is considered one of the most dreaded forms of cancer metastases for both patients and physicians. Aggressive cytoreductive surgery (CRS) is the primary treatment for peritoneal metastasis. Unfortunately, this intensive treatment frequently causes clinical complications, such as postoperative recurrence, metastasis, and adhesion formation. Emerging evidence suggest that neutrophil extracellular traps (NETs) released by inflammatory neutrophils contribute to these complications. Effective NET‐targeting strategies thus show considerable potential in counteracting these complications but remain challenging. Here, we synthesized and screened one type of sulfoxide‐containing homopolymer, PMeSEA, with potent fouling‐resistant and NET‐inhibiting capabilities. Hydrating sulfoxide groups endow PMeSEA with superior non‐fouling ability, significantly inhibiting protein/cell adhesion. Besides, the polysulfoxides can be selectively oxidized by ClO – which is required to stabilize the NETs rather than H 2 O 2 , and ClO – scavenging effectively inhibits NETs formation without disturbing redox homeostasis in tumor cells and quiescent neutrophils. As a result, PMeSEA potently prevents postoperative adhesions, significantly suppresses peritoneal metastasis, and shows synergetic antitumor activity with chemotherapeutic 5‐Fluorouracil. Moreover, coupling aggressive cytoreductive surgery (CRS) with PMeSEA potently inhibits CRS‐induced tumor metastatic relapse and postoperative adhesions. Notably, PMeSEA exhibits low in vivo acute and subacute toxicities, implying significant potential for clinical postoperative adjuvant treatment. This article is protected by copyright. All rights reserved
科研通智能强力驱动
Strongly Powered by AbleSci AI